Lipella Pharmaceuticals Inc. Common Stock (LIPO) — Net Asset Momentum
Lipella Pharmaceuticals Inc. Common Stock (LIPO) recorded a net asset momentum of -39.0% as of December 2024, with net assets of $1.92 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of Lipella Pharmaceuticals Inc. Common Stoc to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Lipella Pharmaceuticals Inc. Common Stock Net Asset Momentum (2019–2024)
This chart tracks Lipella Pharmaceuticals Inc. Common Stock's year-over-year net asset growth across 6 annual reporting periods from 2019 to 2024. The most recent momentum reading is -39.0%, with net assets of $1.92 Million USD as of December 2024. Read Lipella Pharmaceuticals Inc. Common Stoc balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Lipella Pharmaceuticals Inc. Common Stock (2019–2024)
The table below shows the complete annual net asset history for Lipella Pharmaceuticals Inc. Common Stock from 2019 to 2024, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see LIPO market cap overview.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | $1.92 Million | $2.67 Million | $754.42K | ▼ -39.0% |
| 2023 | $3.14 Million | $3.58 Million | $432.73K | ▼ -32.7% |
| 2022 | $4.68 Million | $5.95 Million | $1.27 Million | ▲ +228.4% |
| 2021 | $1.42 Million | $2.01 Million | $589.34K | ▲ +207.3% |
| 2020 | $463.32K | $955.02K | $491.70K | ▲ +491.5% |
| 2019 | $-118.34K | $118.92K | $237.26K | — |